Eli Lilly & Co
LLY· NYSE
Released Aug 4, 2022, before the open
10-Q filed Aug 4, 2022, 35 days after period end · 0000059478-22-000196
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $6.49B | $6.74B | $5.50B | $5.64B |
| Net Income | $952.50M | $1.39B | $1.41B | $1.33B |
| EPS Diluted |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $1.05 |
| $1.53 |
| $1.55 |
| $1.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.